As of June 13, 2025, Neuropathix Inc (NPTX) reports a Graham Number of N/A.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Neuropathix Inc's Graham Number
Over recent years, Neuropathix Inc's Graham Number has shown significant volatility. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2021-12-31 | - |
| 2020-12-31 | 0.06 |
| 2019-12-31 | 0.00 |
This steady improvement highlights how Neuropathix Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Neuropathix Inc's Graham Number to Peers
To better understand Neuropathix Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Neuropathix Inc (NPTX) | - |
| BiondVax Pharmaceuticals Ltd (BVXV) | 7.84 |
| Context Therapeutics Inc (CNTX) | 6.68 |
| Acura Pharmaceuticals Inc (ACUR) | 0.19 |
Compared to its competitors, Neuropathix Inc's Graham Number is difficult to compare due to insufficient data.